Bain Capital Investor Portal Please log in to access your account information. If you have any questions regarding your account, please contact [email protected].
Emeryville, CA., August 12, 2019 – Dynavax Technologies Corporation (NASDAQ: DVAX), a biopharmaceutical company focused on commercializing novel vaccines, today announced Andrew A. F. Hack, M.D., Ph.D., a Managing Director at Bain Capital Life Sciences, has been appointed to Dynavax’s Board of Directors. The appointment follows an investment by Bain Capital Life Sciences in Dynavax’s...
SOUTH SAN FRANCISCO, CA, December 19, 2018 - Annexon Biosciences, a clinical stage biopharmaceutical company focused on the development of novel therapeutics through inhibition of the classical complement pathway, today announced that it has closed a $75 million Series C financing. The financing was led by new investor Bain Capital Life Sciences, with participation by Surveyor Capital (a Citadel...
SAN DIEGO, November 29, 2018 – ViaCyte, Inc., a privately-held clinical stage regenerative medicine company, today announced an $80 million Series D financing led by Bain Capital Life Sciences and joined by TPG and RA Capital Management, as well as existing investor, Sanderling Ventures, and several individual supporters of the Company. Proceeds from the financing will be used to further...
BOSTON and NEW YORK, October 23, 2018 – Bain Capital, LP and Pfizer Inc. (NYSE: PFE) today announced the creation of Cerevel Therapeutics, LLC (“Cerevel”), a new biopharmaceutical company focused on developing drug candidates to treat disorders of the central nervous system (CNS). Pfizer is contributing a portfolio of pre-commercial neuroscience assets to Cerevel, which include three...
LOWELL, MA, May 2, 2018 – Rapid Micro Biosystems, the leading provider of automated, growth-based, rapid microbial detection technology for the healthcare product manufacturing sector, announced that it has secured $60 million in equity financing led by new investors Bain Capital Life Sciences and Xeraya Capital. The new funding round also includes a commitment from another new investor, Asahi...
EVANSTON, ILLINOIS, December 18, 2017 – Aptinyx Inc., a clinical-stage biopharmaceutical company developing transformative therapies for challenging neurologic disorders, today is announcing the completion of a $70 million Series B financing to fund advancement of its expanding clinical-stage pipeline. The financing was led by Bain Capital Life Sciences. Additional new investors include Adage...
JENA, GERMANY, October 13, 2017 - InflaRx, the biopharmaceutical company developing new therapeutics in the terminal complement space, announced today a $ 55M Series D financing and investment round. The round was co-led by Bain Capital Life Sciences LP, Cormorant Asset Management LLC and RA Capital Management LLC and complemented by certain investment funds managed by a leading US investment...
NEW YORK, September 25, 2017 - SpringWorks Therapeutics, a mission-driven medicines company dedicated to developing innovative potential new treatments for underserved patient communities, announced its launch today with a completed $103 million Series A financing funded by Bain Capital Life Sciences, Bain Capital Double Impact, OrbiMed, Pfizer (NYSE:PFE) and LifeArc (formerly known as...
WOBURN, MA, September 8, 2017 – Replimune Group Inc., a biotechnology company focused on developing next generation oncolytic immunotherapies, announced today the completion of a $55 million Series B financing. The proceeds of the financing will primarily be used to generate human proof of concept data for its lead product, RP1, in multiple tumor types. The financing will also allow the Company...
CAMBRIDGE, MA, March 30, 2017 - Solid Biosciences announced today that it has completed the initial closing of its $50 Million Series C financing, which the company will use to progress its portfolio of programs targeted at Duchenne muscular dystrophy (DMD). The round was led by RA Capital Management and Bain Capital Life Sciences, together with funds from RTW Investments, Foresite Capital,...
Most people never even get a second chance at life. Imagine how it must feel to have a third chance. Thanks to… https://t.co/3tczNgUlMz
Do you know how bone marrow transplants work? Few people know the procedure better than Dr. Catherine Wu, one of… https://t.co/ft3WTFRKbi
A little pedal power goes a long way... all the way to $220 million. Join @Cycle4Survival and @sloan_kettering in t… https://t.co/M3dmLwX444
How does @CityYear help a growing number of students in need, year after year? Partnerships with organizations like… https://t.co/JxVTmwDAVy
The third annual Boston Eats Festival, hosted by @TestKitchen and supported by @communityserv, will kick off on Oct… https://t.co/0QT5WtYi9R
Kids like Lia Scagnoli give us hope for the future. This 10-year-old cancer survivor is bringing some joy to the li… https://t.co/qIVxGWBlL2
Congratulations to @YearUp Greater Atlanta -- it's their 10th anniversary this month! https://t.co/D9I41HmukA #BainCapitalCP
When times are tough and temperatures are dropping, simple things can have a big impact on peoples' lives.… https://t.co/YeRRclLL17
Are you ready to ride against cancer? Registration with @Cycle4Survival is now open -- get your bike on for a cause… https://t.co/oZaYlJ0YWF
If you like good food, great people, and worthy causes, you'd better come out to the @communityserv Young Professio… https://t.co/CC9VIXhPNp